GeneOne Life Science Inc. (KOSE:A011000) announced a private placement of fourth unregistered unguaranteed coupon private convertible bonds for gross proceeds of KRW 24,000,000,000 on November 23, 2020. The bonds will mature on November 25, 2023, carry a fixed zero annual coupon and yield to maturity of 3%. The bonds will be convertible into common shares of the company at a rate of 100% and at a fixed conversion price of KRW 27,143 per share for a conversion period starting from November 25, 2021 to October 25, 2023.

The bonds will be issued at par. The transaction will include participation from Hanyang Securities Co. Ltd. (KOSE:A001750).

for KRW 5,300,000,000, Hana Financial Investment Co., Ltd. for KRW 3,000,000,000, Mirae Asset Daewoo Co., Ltd. (KOSE:A006800) for KRW 3,000,000,000. The subscription date and payment date is November 25, 2020. The transaction has been approved by board of directors of the company.